Cargando…

Cardiorenal ketone metabolism: a positron emission tomography study in healthy humans

Ketones are alternative energy substrates for the heart and kidney but no studies have investigated their metabolism simultaneously in both organs in humans. The present double tracer positron emission tomography (PET) study evaluated the organ distribution and basal kinetic rates of the radiolabele...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuenoud, Bernard, Croteau, Etienne, St-Pierre, Valérie, Richard, Gabriel, Fortier, Mélanie, Vandenberghe, Camille, Carpentier, André C., Cunnane, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587428/
https://www.ncbi.nlm.nih.gov/pubmed/37869718
http://dx.doi.org/10.3389/fphys.2023.1280191
Descripción
Sumario:Ketones are alternative energy substrates for the heart and kidney but no studies have investigated their metabolism simultaneously in both organs in humans. The present double tracer positron emission tomography (PET) study evaluated the organ distribution and basal kinetic rates of the radiolabeled ketone, (11)C-acetoacetate ((11)C-AcAc), in the heart and kidney compared to (11)C-acetate ((11)C-Ac), which is a well-validated metabolic radiotracer. Both tracers were highly metabolized by the left ventricle and the renal cortex. In the heart, kinetic rates were similar for both tracers. But in the renal cortex, uptake of (11)C-Ac was higher compared to (11)C-AcAc, while the reverse was observed for the clearance. Interestingly, infusion of (11)C-AcAc led to a significantly delayed release of radioactivity in the renal medulla and pelvis, a phenomenon not observed with (11)C-Ac. This suggests an equilibrium of (11)C-AcAc with the other ketone, (11)C-D-beta-hydroxybutyrate, and a different clearance profile. Overall, this suggests that in the kidney, the absorption and metabolism of (11)C-AcAc is different compared to (11)C-Ac. This dual tracer PET protocol provides the opportunity to explore the relative importance of ketone metabolism in cardiac and renal diseases, and to improve our mechanistic understanding of new metabolic interventions targeting these two organs.